These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12151117)

  • 1. Use of epileptic animals for adverse effect testing.
    Klitgaard H; Matagne A; Lamberty Y
    Epilepsy Res; 2002 Jun; 50(1-2):55-65. PubMed ID: 12151117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.
    Löscher W
    Prog Neurobiol; 1998 Apr; 54(6):721-41. PubMed ID: 9560847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
    Wlaź P; Ebert U; Potschka H; Löscher W
    Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corneal kindling in mice: behavioral and pharmacological differences to conventional kindling.
    Potschka H; Löscher W
    Epilepsy Res; 1999 Nov; 37(2):109-20. PubMed ID: 10510977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs.
    Meldrum B
    Epilepsy Res; 2002 Jun; 50(1-2):33-40. PubMed ID: 12151115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs.
    Hönack D; Löscher W
    Epilepsia; 1995 Aug; 36(8):763-71. PubMed ID: 7635095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice.
    De Sarro G; Palma E; Costa N; Marra R; Gratteri S; De Sarro A; Rotiroti D
    Neuropharmacology; 2000 Aug; 39(11):2147-61. PubMed ID: 10963758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
    Villetti G; Bregola G; Bassani F; Bergamaschi M; Rondelli I; Pietra C; Simonato M
    Neuropharmacology; 2001 Jun; 40(7):866-78. PubMed ID: 11378157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats.
    De Sarro G; Di Paola ED; Gareri P; Gallelli L; Scotto G; De Sarro A
    Eur J Pharmacol; 1999 Mar; 368(2-3):149-59. PubMed ID: 10193651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated acute testing of anticonvulsant drugs in amygdala kindled rats: increase in anticonvulsant but decrease in adverse effect potential.
    Löscher W; Fiedler M
    Epilepsia; 2000 May; 41(5):516-28. PubMed ID: 10802756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy.
    Rundfeldt C; Wlaź P; Löscher W
    Brain Res; 1994 Aug; 653(1-2):125-30. PubMed ID: 7982045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limbic epileptogenesis alters the anticonvulsant efficacy of phenytoin in Sprague-Dawley rats.
    Löscher W; Cramer S; Ebert U
    Epilepsy Res; 1998 Aug; 31(3):175-86. PubMed ID: 9722028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats.
    Potschka H; Fedrowitz M; Löscher W
    Eur J Pharmacol; 1999 Jun; 374(2):175-87. PubMed ID: 10422758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?
    Löscher W
    Neurochem Res; 2017 Jul; 42(7):1926-1938. PubMed ID: 27502939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs.
    White HS
    Epilepsia; 1997; 38 Suppl 1():S9-17. PubMed ID: 9092952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.